By CHAD BRAY
The European private equity firm will buy a controlling share in the German laboratory testing company, in a deal that values Synlab at about $2 billion.
Published: June 27, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1RBYSdU
from WordPress http://ift.tt/1J9fW92
via Hadi Aboukhater
No comments:
Post a Comment